In diabetics and CKD patients, several molecular pathways linking chronic inflammation and anisocytosis have been proposed: shortened erythrocyte lifespan, inhibited erythropoietin response and impaired iron metabolism [15,16]. The gene discussed is EPO; the disease is chronic kidney disease.